NantOmics

About:

NantOmics develops cloud-based molecular profiling tools that help guide cancer patients.

Twitter/X: nantomics

Top Investors: NantHealth

Description:

NantOmics develops cloud-based molecular profiling tools that help guide cancer patients. It is a molecular diagnostics company, develops molecular profiling solutions that identify personalized treatment options for cancer patients and their providers at the point of care. It offers GPS Cancer test that provides a molecular profile of patient’s cancer to inform personalized treatment strategies to oncologists and OncoPlexDx Targeted Proteomic panel that provides quantitative protein biomarker information for multiple clinically relevant proteins yielding insights into the biology driving the growth of the patient’s cancer. Patrick Soon-Shiong founded NantOmics in 2012, with its headquarters in Culver City, California. NantOmics operates as a subsidiary of NantWorks.

Total Funding Amount:

$251M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Culver City, California, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)nantomics.com

Hub Tags:

Unicorn

Founders:

Patrick Soon-Shiong

Number of Employees:

11-50

Last Funding Date:

2015-06-01

IPO Status:

Private

Industries: